Free Trial
NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

Nutex Health logo
$22.29
-1.25 (-5.31%)
(As of 10/31/2024 ET)

About Nutex Health Stock (NASDAQ:NUTX)

Key Stats

Today's Range
$21.80
$24.64
50-Day Range
$18.50
$25.19
52-Week Range
$4.16
$45.00
Volume
49,815 shs
Average Volume
40,395 shs
Market Capitalization
$112.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.00
Consensus Rating
Buy

Company Overview

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

Nutex Health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
72nd Percentile Overall Score

NUTX MarketRank™: 

Nutex Health scored higher than 72% of companies evaluated by MarketBeat, and ranked 308th out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nutex Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Nutex Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutex Health is -2.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutex Health is -2.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nutex Health has a P/B Ratio of 1.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nutex Health's valuation and earnings.
  • Percentage of Shares Shorted

    3.39% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutex Health has recently decreased by 33.04%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Nutex Health does not currently pay a dividend.

  • Dividend Growth

    Nutex Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.39% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutex Health has recently decreased by 33.04%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Nutex Health has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Nutex Health this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for NUTX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutex Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $52,176.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    38.52% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.32% of the stock of Nutex Health is held by institutions.

  • Read more about Nutex Health's insider trading history.
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

NUTX Stock News Headlines

Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…
Nutex Health Inc (NUTX) Shares Up 5.48% on Oct 2
See More Headlines

NUTX Stock Analysis - Frequently Asked Questions

Nutex Health's stock was trading at $27.00 at the start of the year. Since then, NUTX shares have decreased by 17.4% and is now trading at $22.29.
View the best growth stocks for 2024 here
.

Nutex Health Inc. (NASDAQ:NUTX) released its quarterly earnings results on Thursday, August, 8th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.22. The company had revenue of $76.08 million for the quarter. Nutex Health had a negative net margin of 13.73% and a negative trailing twelve-month return on equity of 43.79%.

Shares of Nutex Health reverse split on Wednesday, July 3rd 2024. The 1-10 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional shareholders of Nutex Health include Essex Investment Management Co. LLC (1.46%), One Plus One Wealth Management LLC (0.76%) and International Assets Investment Management LLC (0.17%). Insiders that own company stock include Thomas T Vo, Joshua Detillio, Jon Christian Bates, John J Waters, Pamela W Montgomery and Michael Lee Reed.
View institutional ownership trends
.

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutex Health investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Bank of America (BAC) and Cricut (CRCT).

Company Calendar

Last Earnings
8/08/2024
Today
10/31/2024
Next Earnings (Estimated)
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
Business Services
Current Symbol
NASDAQ:NUTX
Employees
1,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$45.00
High Stock Price Target
$45.00
Low Stock Price Target
$45.00
Potential Upside/Downside
+101.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-45,790,000.00
Pretax Margin
-11.53%

Debt

Sales & Book Value

Annual Sales
$275.93 million
Book Value
$17.68 per share

Miscellaneous

Free Float
3,115,000
Market Cap
$112.92 million
Optionable
Not Optionable
Beta
0.10
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:NUTX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners